Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06932042

PLADO for Conservative Management of CKD

Led by Lebanese American University · Updated on 2025-04-17

48

Participants Needed

1

Research Sites

109 weeks

Total Duration

On this page

Sponsors

L

Lebanese American University

Lead Sponsor

Z

Zayed University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if a plant-dominant low protein diet, referred to as PLADO diet, works to decrease metabolic acidosis, a major risk factor for chronic kidney disease (CKD) progression, in adults with CKD. It will also learn about the safety, viability, and economic attractiveness of this diet. The main questions it aims to answer are: * Is the PLADO diet more effective in managing metabolic acidosis in comparison with the standard-of-care CKD diet in adults with CKD? * Is the PLADO diet safe, viable, and economically attractive adults with CKD? Researchers will compare the PLADO diet to the standard-of-care CKD diet to see if the PLADO diet works better to decrease metabolic acidosis. Participants will: * Receive nutrition education of the PLADO diet or the standard-of-care CKD diet via monthly sessions for 6 months. * Visit the clinic monthly for 6 months, then after 3 months for checkups and tests.

CONDITIONS

Official Title

PLADO for Conservative Management of CKD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years and above
  • Diagnosed with stages 3 to 5 chronic kidney disease with estimated GFR 9 ml/min/1.73 m2 stable for at least three months
  • Controlled blood sugar and blood pressure levels on treatment
  • Normal nutritional status as defined by GLIM criteria
  • Willing to undergo baseline screening and attend monthly face-to-face visits at the outpatient department
Not Eligible

You will not qualify if you...

  • Overt infection, persistent anorexia, vomiting, or diarrhea within the last month
  • Presence of wasting diseases such as cancer, tuberculosis, liver failure, or heart failure
  • Serum potassium level greater than 5.5 mEq/L during the past 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lebanese American University Medical Center- Rizk Hospital

Beirut, Lebanon

Actively Recruiting

Loading map...

Research Team

R

Rana Rizk, PhD, MS, MPH, LD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here